Symbidia Limited (the \"Company\") was founded to create exceptional software in the healthcare area based on advanced technologies for the Greater China and Asia Pacific regions. The goal is to offer clients software solutions based on the same technology as the large international software companies but at a much lower cost and targeted specifically to the clients’ needs. There is clear demand by companies in the Greater China and Asia Pacific regions for alternative, low-cost IT solutions that would increase their competitiveness.
Symbidia Limited was founded in 1999. The Company is headquartered in Hong Kong,has a business branch and a development center in Beijing and Shanghai respectively. It is in the process of seeking to develop representations in Korea and Taiwan. Its two major shareholders are Incubate Ventures Limited and Brantwood International.
Incubate Ventures is an investment firm that was founded in 1999 providing private equity for early stage companies. Headquartered in Hong Kong, it makes investments in the areas of software and IT services. Incubates’ portfolio companies are in Hong Kong, Taiwan, China, Korea and the USA. In 2001, it established its Korean operation through a joint venture with Dong-A Pharmaceutical, the largest pharmaceutical company in Korea (public: KOSPI) and Haansoft, one of the largest software companies in Korea (public: Kosdaq). In Korea, Incubate has diversified its focus by seeking investments in later stage and buy-out opportunities.
Brantwood International is an investment holding company that makes investments in real estate and infrastructure projects. Headquartered in Hong Kong, its investments are represented in Singapore, Hong Kong, Indonesia and Philippines. Brantwood also hold equity in public vehicles in the respective exchanges. Brantwood has been providing sufficient funding to support the development of health care infrastructure and other social activities in these countries.
Symbidia (Beijing) Limited was founded in April of 2003 by Symbidia Limited Hong Kong. Symbidia Beijing is the business branch of Symbidia Limited and has a vision to become one of the best provider of application software and e-solutions of the health care area.
Symbidia (Shanghai) Limited was founded in October of 2000 by Symbidia Limited Hong Kong. Symbidia Shanghai has become the R&D center for the Symbidia Group making use of the excellent IT environment of Shanghai.
奇辉科技有限公司自成立以来，就以先进的技术创造出适用于中国和亚太地区的优秀医疗类软件。公司的目标是给顾客提供解决方案的软件，而这些软件在技术上与大型的国际性软件公司相同，在价格上却大大降低了顾客的成本，并特别满足顾客的不同要求。这也基于中国和亚太地区的公司非常明确的要求：提供可选择的、低成本的IT解决方案以提高他们的行业管理水平和综合竞争力。
奇辉科技有限公司建立于1999年，公司总部设在香港，在北京设有商务机构，在上海设有技术发展中心，并在韩国和台湾寻求发展。公司的两个主要投资者是Incubate Ventures有限公司和Brantwood International集团。
Incubate Ventures公司建立于1999年，它是一家给私人公司在创业早期提供资金的投资公司，总部设在香港，它的主要投资领域在软件和IT服务，Incubate投资的公司遍及香港，台湾，中国，韩国和美国。2001年，公司在韩国与Dong-A Pharmaceutical和Haansoft公司成立了合资公司，Dong-A Pharmaceutical 公司是韩国最大的医药企业 （股市代号：KOSPI），Haansoft公司是韩国最大的医药类软件企业之一（股市代号：Kosdaq）。在韩国Incubate的投资目标是多元化的，公司也寻找一些成熟的企业进行并购。
Brantwood International集团是一家投资在房地产和基础工程的投资控股公司，总部设于香港，它的投资分布在新加坡、香港、印尼和菲律宾，Brantwood也分别拥有这些地区的上市公司的股份。Brantwood 在这些国家不断地提供基金以支持医疗领域基础建设和其他社会福利事业。
奇辉（北京）成立于2003年4月。奇辉北京是奇辉科技的商务分支机构，欲成为卫生健康领域内的最佳应用软件和e-解决方案提供商之一。
奇辉（上海）成立于2000年10月。奇辉上海是奇辉科技的RD中心，构造于上海极佳的IT环境。
*应聘该职位者请注明薪金要求。
